These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9345062)

  • 1. Deficient drug transporter function of bone marrow-localized and leukemic plasma cells in multiple myeloma.
    Pilarski LM; Szczepek AJ; Belch AR
    Blood; 1997 Nov; 90(9):3751-9. PubMed ID: 9345062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma.
    Pilarski LM; Belch AR
    Blood; 1994 Feb; 83(3):724-36. PubMed ID: 7507731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug resistance in multiple myeloma: cyclosporin A analogues and their metabolites as potential chemosensitizers.
    Pilarski LM; Yatscoff RW; Murphy GF; Belch AR
    Leukemia; 1998 Apr; 12(4):505-9. PubMed ID: 9557608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance in multiple myeloma: novel therapeutic targets within the malignant clone.
    Pilarski LM; Mant MJ; Belch AR
    Leuk Lymphoma; 1999 Jan; 32(3-4):199-210. PubMed ID: 10037018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic expression of the multidrug transporter, P-glycoprotein 170, in multiple myeloma: implications for treatment.
    Pilarski LM; Belch AR
    Leuk Lymphoma; 1995 May; 17(5-6):367-74. PubMed ID: 7549827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug transporter P-glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes: modulation with differentiation stage and during aging.
    Pilarski LM; Paine D; McElhaney JE; Cass CE; Belch AR
    Am J Hematol; 1995 Aug; 49(4):323-35. PubMed ID: 7639278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is multidrug resistance (P-glycoprotein) an intrinsic characteristic of plasma cells in patients with monoclonal gammopathy of undetermined significance, plasmacytoma, multiple myeloma and amyloidosis?
    Mongkonsritragoon W; Kimlinger T; Ahmann G; Greipp PR
    Leuk Lymphoma; 1998 May; 29(5-6):577-84. PubMed ID: 9643571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities.
    Uchida N; Combs J; Chen S; Zanjani E; Hoffman R; Tsukamoto A
    Blood; 1996 Aug; 88(4):1297-305. PubMed ID: 8695847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease.
    Pilarski LM; Giannakopoulos NV; Szczepek AJ; Masellis AM; Mant MJ; Belch AR
    Clin Cancer Res; 2000 Feb; 6(2):585-96. PubMed ID: 10690543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction.
    Szczepek AJ; Seeberger K; Wizniak J; Mant MJ; Belch AR; Pilarski LM
    Blood; 1998 Oct; 92(8):2844-55. PubMed ID: 9763569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
    Jensen GS; Belch AR; Kherani F; Mant MJ; Ruether BA; Pilarski LM
    Scand J Immunol; 1992 Dec; 36(6):843-53. PubMed ID: 1281335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1.
    Hawley TS; Riz I; Yang W; Wakabayashi Y; Depalma L; Chang YT; Peng W; Zhu J; Hawley RG
    Am J Hematol; 2013 Apr; 88(4):265-72. PubMed ID: 23475625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
    Pilarski LM; Seeberger K; Coupland RW; Eshpeter A; Keats JJ; Taylor BJ; Belch AR
    Exp Hematol; 2002 Mar; 30(3):221-8. PubMed ID: 11882359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration.
    Kristensen IB; Pedersen L; Rø TB; Christensen JH; Lyng MB; Rasmussen LM; Ditzel HJ; Børset M; Abildgaard N
    Eur J Haematol; 2013 Sep; 91(3):196-200. PubMed ID: 23607294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain.
    Bergsagel PL; Smith AM; Szczepek A; Mant MJ; Belch AR; Pilarski LM
    Blood; 1995 Jan; 85(2):436-47. PubMed ID: 7529064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Thiago LS; Perez-Andres M; Balanzategui A; Sarasquete ME; Paiva B; Jara-Acevedo M; Barcena P; Sanchez ML; Almeida J; González M; San Miguel JF; Garcia-Sanz R; Orfao A
    Haematologica; 2014 Jan; 99(1):155-62. PubMed ID: 23872308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An increase in MPC-1- and MPC-1-CD45+ immature myeloma cells in the progressive states of bone marrow plasmacytosis: the revised phenotypic classification of monoclonal marrow plasmacytosis (MOMP-2005).
    Otsuyama K; Asaoku H; Kawano MM
    Int J Hematol; 2006 Jan; 83(1):39-43. PubMed ID: 16443550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transduction of MDR1 into human and mouse haemopoietic progenitor cells: use of rhodamine (Rh123) to determine transduction frequency and in vivo selection.
    Hegewisch-Becker S; Hanania EG; Fu S; Körbling M; Deisseroth AB; Andreeff M
    Br J Haematol; 1995 Aug; 90(4):876-83. PubMed ID: 7669666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells.
    Mylin AK; Rasmussen T; Johansen JS; Knudsen LM; Nørgaard PH; Lenhoff S; Dahl IM; Johnsen HE;
    Eur J Haematol; 2006 Nov; 77(5):416-24. PubMed ID: 16930142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma.
    Paiva B; Pérez-Andrés M; Vídriales MB; Almeida J; de las Heras N; Mateos MV; López-Corral L; Gutiérrez NC; Blanco J; Oriol A; Hernández MT; de Arriba F; de Coca AG; Terol MJ; de la Rubia J; González Y; Martín A; Sureda A; Schmidt-Hieber M; Schmitz A; Johnsen HE; Lahuerta JJ; Bladé J; San-Miguel JF; Orfao A; ;
    Leukemia; 2011 Apr; 25(4):697-706. PubMed ID: 21252988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.